2013
DOI: 10.1002/ange.201307505
|View full text |Cite
|
Sign up to set email alerts
|

De Novo Generation of Singlet Oxygen and Ammine Ligands by Photoactivation of a Platinum Anticancer Complex

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
9
0

Year Published

2015
2015
2024
2024

Publication Types

Select...
7
1

Relationship

2
6

Authors

Journals

citations
Cited by 20 publications
(10 citation statements)
references
References 32 publications
1
9
0
Order By: Relevance
“…Moreover, photo-reduction of 1 results in the release not only of Pt II species, but also of other photo-products including azidyl and hydroxyl radicals, nitrenes, and singlet oxygen. 8,9 These photoreduction products can modulate biochemical pathways in tumor cells which are not involved in the MoA of cisplatin and its direct derivatives, thus pointing to a novel MoA for 1. 9 One possibility of how the photoreduction products of 1 might act by an MoA different from that involving DNA damage (and typical for cisplatin and its direct derivatives) is that irradiated 1 could induce an immunogenic form of cell death (ICD).…”
Section: Induction Of Immunogenic Cell Death In Cancer Cells By a Photoactivated Platinum(iv) Prodrug Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Moreover, photo-reduction of 1 results in the release not only of Pt II species, but also of other photo-products including azidyl and hydroxyl radicals, nitrenes, and singlet oxygen. 8,9 These photoreduction products can modulate biochemical pathways in tumor cells which are not involved in the MoA of cisplatin and its direct derivatives, thus pointing to a novel MoA for 1. 9 One possibility of how the photoreduction products of 1 might act by an MoA different from that involving DNA damage (and typical for cisplatin and its direct derivatives) is that irradiated 1 could induce an immunogenic form of cell death (ICD).…”
Section: Induction Of Immunogenic Cell Death In Cancer Cells By a Photoactivated Platinum(iv) Prodrug Introductionmentioning
confidence: 99%
“…It has also been shown 15,[18][19][20] that ICD-associated immunogenicity can be evoked through reactive oxygen species (ROS). Thus, it was reasonable to assume that the photoactivated 1, which generates ROS and RNS, 8,9 could induce, besides apoptosis, also ICD. Therefore, we investigated whether photoactivated 1 can induce ICD in vitro, which could synergistically enhance its anticancer efficiency, thus corroborating the immunomodulating capability of chemotherapy based on this photoactivatable Pt IV prodrug.…”
Section: Induction Of Immunogenic Cell Death In Cancer Cells By a Photoactivated Platinum(iv) Prodrug Introductionmentioning
confidence: 99%
“…In several studies, TD-DFT has been used with great insight to explain the experimentally observed photochemistry of platinum complexes used in PACT. [10][11][12][13][14][15][16][17] In one case, several DFT functionals were also benchmarked against complete active space second-order perturbation theory (CASPT2) and it was concluded that range-separated functionals reproduce both experiment and CASPT2 results best. 18 Surprisingly, none of these investigations have focused on the importance of relativistic effects, in particular concerning explicit inclusion of spin-orbit coupling.…”
Section: Introductionmentioning
confidence: 99%
“…They are further the simplest among a number of related complexes which subsequently have shown similar photoactivity. [11][12][13][14][15][16][17][33][34][35][36][37][38] Their exact mechanism of photo-activation is not known in detail. However, the UV-vis spectra in combination with TD-DFT calculations 10,30 have shown that both trans-and cis-Pt complexes display ligand-to-metal chargetransfer (LMCT) excitations.…”
Section: Introductionmentioning
confidence: 99%
“…11,14 However, the structural evolution and ligand exchange dynamics of platinum(IV) prodrugs, which are important to their photoactivity, are not yet fully understood. 12,13,15 Moreover, the behaviors of these antitumor prodrugs in protic and aprotic solvents are much less understood. A better understanding of the structure and dynamics of these platinum-based prodrug complexes will contribute to illustrating their interactions with the key active biological molecules in cancer cells.…”
Section: Introductionmentioning
confidence: 99%